
Tilray Brands, Canopy Growth, and Aurora Cannabis are the three Cannabis stocks to watch today, according to MarketBeat’s stock screener tool. Cannabis stocks are shares of publicly traded companies whose primary business involves the cannabis plant or its products—including cultivation, processing, distribution, retail, biotech (medical products), and ancillary services or equipment. For investors, these equities are typically higher-risk, higher-volatility plays influenced strongly by regulatory and legal changes, licensing, and shifting consumer/medical demand. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.
Tilray Brands (TLRY)
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.
Canopy Growth (CGC)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
Read Our Latest Research Report on CGC
Aurora Cannabis (ACB)
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Read Our Latest Research Report on ACB
Recommended Stories
- MarketBeat’s Top Five Stocks to Own in November 2025
- Sticker Shock: Why Kimberly-Clark’s Sell-Off Is an Overreaction
- Why Hims & Hers Stock May Be a Buy After Mixed Q3 Results
- Why Apple’s Next Quarter Could Be a “Prove It” iPhone 17 Moment
- 3 Reasons Tesla Could Be a $500 Stock by the End of the Month
- Affirm’s New York Life Deal: A Game-Changing Stamp of Approval
